within Pharmacolibrary.Drugs.ATC.J;

model J05AR07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.0006666666666666666,
    adminDuration  = 600,
    adminMass      = 0.3,
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Stavudine, lamivudine, and nevirapine is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection. Each component targets HIV replication by different mechanisms: stavudine and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs), while nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). This combination remains in use in resource-limited settings but is not a preferred regimen in current HIV treatment guidelines due to concerns about toxicity and resistance.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated based on published ranges for healthy adult HIV-infected patients receiving the fixed-dose combination orally.</p><h4>References</h4><ol><li><p>Chokephaibulkit, K, et al., &amp; Vanprapar, N (2005). Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. <i>AIDS (London, England)</i> 19(14) 1495–1499. DOI:<a href=&quot;https://doi.org/10.1097/01.aids.0000183625.97170.59&quot;>10.1097/01.aids.0000183625.97170.59</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16135903/&quot;>https://pubmed.ncbi.nlm.nih.gov/16135903</a></p></li><li><p>Vanprapar, N, et al., &amp; Yogev, R (2010). A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. <i>The Pediatric infectious disease journal</i> 29(10) 940–944. DOI:<a href=&quot;https://doi.org/10.1097/INF.0b013e3181e2189d&quot;>10.1097/INF.0b013e3181e2189d</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20453709/&quot;>https://pubmed.ncbi.nlm.nih.gov/20453709</a></p></li><li><p>Pollock, L, et al., &amp; Khoo, S (2009). Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets. <i>The Journal of antimicrobial chemotherapy</i> 64(6) 1251–1259. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkp358&quot;>10.1093/jac/dkp358</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19812065/&quot;>https://pubmed.ncbi.nlm.nih.gov/19812065</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J05AR07;
